The FDA has approved a number of gadolinium-based contrast agents. These contrast agents include Magnevist, MultiHance, Omniscan, OptiMARK, and ProHance. 

While the use of these drugs has been associated with NSF, they still have FDA approval. One reason for maintaining this approval is that medical reports have not gathered enough information about the correlation between gadolinium and NSF. 

If you have beeen diagnosed with NSF and been exposed to a gadolinium-based contrast agent, contact the gadolimium lawyers of Williams Kherkher at 800-761-3187.